OXOLIFE Confirms the Safety of OXO-001 in Women of Childbearing Age in a Phase I Clinical Trial
OXOLIFE has published the results of a Phase I clinical trial in the International Journal of Fertility & Sterility, evaluating the safety, tolerability, and pharmacokinetics of the compound OXO-001 in healthy women of childbearing age. The randomized, double-blind, placebo-controlled study included 30 volunteers. Results showed that OXO-001 was well-tolerated, with no serious adverse events or […]